微生物组合的变化和克隆移植在便微生物群的第三阶段试验中,对于复发性Clostridioides difficile感染而言
Josh Claypool1, Gustav Lindved2, Pernille Neve Myers2
1Ferring Microbiome, Inc, Roseville, MN, USA.
Gut microbes
|June 24, 2025
概括
便微生物群,活体jslm (RBL) 在复发性Clostridioides difficile感染 (rCDI) 患者中有效地恢复肠道微生物组合. 来自RBL的细菌菌株植入了响应者,长期存在并有助于制药动力学分析.
科学领域:
- 微生物组研究的研究.
- 胃肠病学 胃肠病学
- 药理动力学是什么意思 药理动力学
背景情况:
- 活微生物群疗法显示出对胃肠道疾病的潜力.
- 需要对这些疗法进行药理动力学和药理动力学分析的框架.
- 便微生物群,活体jslm (RBL) 是FDA批准的用于预防复发性Clostridioides difficile感染 (rCDI).
研究的目的:
- 分析接受RBL.参与者的肠道微生物组合变化和细菌菌株移植.
- 建立一种方法来探索基于微生物群的治疗方法的克隆移植.
- 为了促进未来对活微生物群疗法的药理动力学和药理动力学分析.
主要方法:
- 使用了深度猎枪元基因组测序.
- 分析的重点是肠道微生物组合的变化.
- 对从RBL移植到接受者的细菌克隆群体植入进行了评估.
主要成果:
- RBL响应者在1周内显示肠道微生物群的变化类似于健康的捐赠者.
- 来自RBL的克隆种群植入接受者,在响应者中植入率更高.
- 植入的种群,包括Bacteroidia物种,在许多反应者中持续了≥6个月.
结论:
- 像RBL这样的活微生物群疗法可以恢复肠道微生物组合,并促进菌株移植.
- 响应者中RBL衍生菌株的高植入率和持久性支持它们的治疗效果.
- 该研究提供了一种分析克隆移植的方法,这对于微生物群治疗药物的药理动力学和药理动力学研究至关重要.
相关概念视频
Bacterial Flora of the Large Intestine
657
The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
657
Drugs for Treatment of Diarrhea-Predominant IBS
313
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
313
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
278
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
278
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
430
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
430
Inflammatory Bowel Disease II: Crohn's Disease
401
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
401
Drugs for Treatment of Ulcerative Colitis in IBD
244
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
244


